SonoVue

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
AIM To evaluate in a multicenter study whether the sonographic characterization of focal liver lesions can be improved using… (More)
Is this relevant?
2009
2009
Experiments were performed to measure the dynamical response of individual SonoVue microbubbles subjected to pulsed ultrasound… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Delayed parenchymal phase images of the liver more than 5 min after IV injection of ultrasound contrast agents are thought to be… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The aim of the present retrospective study was to assess the incidence of adverse events (AE) of a second-generation ultrasound… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
AIM To evaluate the contrast-enhanced endosonography as a method of differentiating inflammation from pancreatic carcinoma based… (More)
Is this relevant?
2005
2005
AIM SonoVue is the first ultrasound contrast agent which allows repeated continuous examination of the liver in real time. The… (More)
Is this relevant?
2005
2005
Conventional ultrasonography (US) has limited accuracy in the detection and characterisation of solid focal liver lesions (FLL… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE We investigated the ability of contrast-enhanced sonography with SonoVue (Altana Pharma, Konstanz, Germany), a sulfur… (More)
Is this relevant?
2004
2004
Though long considered unlikely because of the resonance pattern of agents such as SonoVue, high frequency applications for small… (More)
Is this relevant?
Review
2000
Review
2000
SonoVue is a second-generation ultrasound contrast agent consisting of phospholipid-stabilized microbubbles filled with sulfur… (More)
Is this relevant?